Elanco Animal Health (ELAN) Competitors

BioNTech (NASDAQ:BNTX) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

Is BNTX or ELAN more profitable?

Elanco Animal Health has a net margin of 4.60% compared to BioNTech's net margin of -15.16%. Elanco Animal Health's return on equity of 6.78% beat BioNTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioNTech	-15.16%	-2.35%	-2.05%
Elanco Animal Health	4.60%	6.78%	3.03%

Which has higher valuation and earnings, BNTX or ELAN?

BioNTech has higher earnings, but lower revenue than Elanco Animal Health. BioNTech is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioNTech	$2.75B	9.33	$1.01B	-$3.40	-31.34
Elanco Animal Health	$4.43B	1.55	-$1.23B	$0.74	18.68

Which has more risk and volatility, BNTX or ELAN?

BioNTech has a beta of 1.29, indicating that its stock price is 29% more volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500.

Do analysts prefer BNTX or ELAN?

BioNTech currently has a consensus target price of $138.25, indicating a potential upside of 29.72%. Elanco Animal Health has a consensus target price of $15.17, indicating a potential upside of 9.74%. Given BioNTech's stronger consensus rating and higher possible upside, analysts clearly believe BioNTech is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioNTech	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.83
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Do institutionals & insiders hold more shares of BNTX or ELAN?

15.5% of BioNTech shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 19.2% of BioNTech shares are held by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Does the media favor BNTX or ELAN?

In the previous week, BioNTech had 19 more articles in the media than Elanco Animal Health. MarketBeat recorded 24 mentions for BioNTech and 5 mentions for Elanco Animal Health. BioNTech's average media sentiment score of 0.54 beat Elanco Animal Health's score of 0.36 indicating that BioNTech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BioNTech	7 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive
Elanco Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer BNTX or ELAN?

BioNTech received 7 more outperform votes than Elanco Animal Health when rated by MarketBeat users. However, 54.96% of users gave Elanco Animal Health an outperform vote while only 47.04% of users gave BioNTech an outperform vote.

Company	Underperform	Outperform
BioNTech	Outperform Votes 151 47.04%	Underperform Votes 170 52.96%
Elanco Animal Health	Outperform Votes 144 54.96%	Underperform Votes 118 45.04%

Summary

BioNTech beats Elanco Animal Health on 10 of the 19 factors compared between the two stocks.